These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30202014)

  • 1. Computational systems pharmacology analysis of cannabidiol: a combination of chemogenomics-knowledgebase network analysis and integrated in silico modeling and simulation.
    Bian YM; He XB; Jing YK; Wang LR; Wang JM; Xie XQ
    Acta Pharmacol Sin; 2019 Mar; 40(3):374-386. PubMed ID: 30202014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
    Elmes MW; Kaczocha M; Berger WT; Leung K; Ralph BP; Wang L; Sweeney JM; Miyauchi JT; Tsirka SE; Ojima I; Deutsch DG
    J Biol Chem; 2015 Apr; 290(14):8711-21. PubMed ID: 25666611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of molecular targets and signaling pathways for CBD.
    de Almeida DL; Devi LA
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00682. PubMed ID: 33169541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.
    Jakowiecki J; Abel R; Orzeł U; Pasznik P; Preissner R; Filipek S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors.
    Dávila EM; Patricio F; Rebolledo-Bustillo M; Garcia-Gomez D; Hernandez JCG; Sanchez-Gaytan BL; Limón ID; Perez-Aguilar JM
    Front Pharmacol; 2022; 13():945935. PubMed ID: 36016551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Network Pharmacology Approach to Identify Potential Molecular Targets for Cannabidiol's Anti-Inflammatory Activity.
    Ma H; Xu F; Liu C; Seeram NP
    Cannabis Cannabinoid Res; 2021 Aug; 6(4):288-299. PubMed ID: 33998855
    [No Abstract]   [Full Text] [Related]  

  • 8. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation.
    Vitale RM; Iannotti FA; Schiano Moriello A; Tunisi L; Piscitelli F; Savopoulos R; Cristino L; De Petrocellis L; Amodeo P; Gray R; Di Marzo V
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.
    McHugh D; Hu SS; Rimmerman N; Juknat A; Vogel Z; Walker JM; Bradshaw HB
    BMC Neurosci; 2010 Mar; 11():44. PubMed ID: 20346144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight of Captagon Abuse by Chemogenomics Knowledgebase-guided Systems Pharmacology Target Mapping Analyses.
    Wu N; Feng Z; He X; Kwon W; Wang J; Xie XQ
    Sci Rep; 2019 Feb; 9(1):2268. PubMed ID: 30783122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study.
    Chung H; Fierro A; Pessoa-Mahana CD
    PLoS One; 2019; 14(7):e0220025. PubMed ID: 31335889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic and Natural Derivatives of Cannabidiol.
    Morales P; Jagerovic N
    Adv Exp Med Biol; 2021; 1297():11-25. PubMed ID: 33537934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment.
    Stark T; Di Bartolomeo M; Di Marco R; Drazanova E; Platania CBM; Iannotti FA; Ruda-Kucerova J; D'Addario C; Kratka L; Pekarik V; Piscitelli F; Babinska Z; Fedotova J; Giurdanella G; Salomone S; Sulcova A; Bucolo C; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V
    Biochem Pharmacol; 2020 Jul; 177():114004. PubMed ID: 32360362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents.
    Lin XH; Yuece B; Li YY; Feng YJ; Feng JY; Yu LY; Li K; Li YN; Storr M
    Neurogastroenterol Motil; 2011 Sep; 23(9):862-e342. PubMed ID: 21726355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design, synthesis and testing of desoxy-CBD: further evidence for a region of steric interference at the cannabinoid receptor.
    Reggio PH; Bramblett RD; Yuknavich H; Seltzman HH; Fleming DN; Fernando SR; Stevenson LA; Pertwee RG
    Life Sci; 1995; 56(23-24):2025-32. PubMed ID: 7776828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benchmarking GPCR homology model template selection in combination with de novo loop generation.
    Szwabowski GL; Castleman PN; Sears CK; Wink LH; Cole JA; Baker DL; Parrill AL
    J Comput Aided Mol Des; 2020 Oct; 34(10):1027-1044. PubMed ID: 32737667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Ligand Binding to GPCRs Through Computational Methods.
    Vasile S; Esguerra M; Jespers W; Oliveira A; Sallander J; Åqvist J; Gutiérrez-de-Terán H
    Methods Mol Biol; 2018; 1705():23-44. PubMed ID: 29188557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAKB-GPCRs: An Integrated Computational Platform for Drug Abuse Related GPCRs.
    Chen M; Jing Y; Wang L; Feng Z; Xie XQ
    J Chem Inf Model; 2019 Apr; 59(4):1283-1289. PubMed ID: 30835466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.